1
项与 Human fetal-derived Neural Stem Cells(Ospedale San Raffaele) 相关的临床试验Neural Stem Cell Transplantation in Multiple Sclerosis Patient: a Phase I Study
This is a phase I study evaluating the feasibility, safety and tolerability of intrathecally administered human Neural Stem Cells (hNSCs), at an escalating dose ranging from 0.7x10^6±10% cells to 5.7x10^6±10% cells/kg of body weight, in patients affected by Progressive Multiple Sclerosis
100 项与 Human fetal-derived Neural Stem Cells(Ospedale San Raffaele) 相关的临床结果
100 项与 Human fetal-derived Neural Stem Cells(Ospedale San Raffaele) 相关的转化医学
100 项与 Human fetal-derived Neural Stem Cells(Ospedale San Raffaele) 相关的专利(医药)
100 项与 Human fetal-derived Neural Stem Cells(Ospedale San Raffaele) 相关的药物交易